Prescribing Psychotropics bridges the gap between the complexities of drug pharmacokinetics and everyday clinical practice, providing clinicians more insight into how psychiatric drugs behave (or misbehave!) once their patients take them.
This week we’re talking about a new company called Positive Development, which offers developmental therapies paid for by insurance, currently in Florida, New Jersey, California, and coming soon to Illinois. Maryanne Nugent is the Chief Operating Officer and the parent of a 23-year-old son who received DIR/Floortime when he was 3. Returning guest, Dr. Joshua Feder, is the Medical Director, an Expert Training Leader in the Developmental, Individual differences, Relationship-based (DIR) Model and a child and family psychiatrist, among other things as we know from our past podcasts.
https://affectautism.com/2021/07/31/positive-development/
You Might Also Enjoy...
Prescribing Psychotropics bridges the gap between the complexities of drug pharmacokinetics and everyday clinical practice, providing clinicians more insight into how psychiatric drugs behave (or misbehave!) once their patients take them.
As leaders we want to be kind while being effective, and this can be difficult. How do make sure that we do not become tired and angry but instead stay fresh and creative? Hear Zoe Kernohan Neely, Josh Feder MD & Jerri Lynn Hogg PhD in three mini videos.
This deep dive podcast breaks through the dogma of autism intervention and helps you to understand three main branches of autism intervention and their very different mechanisms, with a huge shift in our understanding of what works.
We break down three main autism intervention approaches, and provide you with information that will help you improve on your abilities to recognize which particular autism intervention might be best for a specific patient.
It's all over the internet: a new non-stimulant medication approved by the FDA for treatment of ADHD. but is Viloxazine (Qelbree) going to be a game changer? Find out!
There's so much marketing for genetic testing, but does it really help clinical care? Listen to our interview with Dr. Aaron Besterman about how genetic tests work, and what can be reliably taken away from them.